 |
|
|
Dec '01 |
Mar '02 |
Jun '02 |
Sep '02 |
Dec '02 |
|
| Sales Turnover |
0.14 |
0.26 |
0.02 |
0.02 |
-- |
| Other Income |
-- |
0.44 |
-- |
-- |
-- |
| Total Income |
0.14 |
0.70 |
0.02 |
0.02 |
-- |
| Total Expenses |
0.35 |
0.27 |
0.14 |
0.15 |
0.13 |
| Operating Profit |
-0.21 |
-0.01 |
-0.12 |
-0.13 |
-0.13 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
-0.21 |
0.43 |
-0.12 |
-0.13 |
-0.13 |
| Interest |
6.02 |
7.34 |
6.35 |
6.40 |
6.40 |
| PBDT |
-6.24 |
-6.92 |
-6.47 |
-6.54 |
-6.53 |
| Depreciation |
1.97 |
1.99 |
1.74 |
1.74 |
1.74 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
-8.21 |
-8.91 |
-8.21 |
-8.28 |
-8.27 |
| Tax |
-- |
-- |
-- |
-- |
-- |
| Net Profit |
-8.21 |
-8.91 |
-8.21 |
-8.28 |
-8.27 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
-- |
-- |
-- |
-- |
-- |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
19.99 |
20.43 |
20.43 |
20.43 |
20.43 |
| Reserves |
-- |
83.30 |
83.30 |
83.30 |
83.30 |
| Face Value |
10.00 |
10.00 |
10.00 |
10.00 |
10.00 |
|
|
|
|
|
| BSE: 500455 |
NSE: PAAMPHARMA |
Reuters: PAAM.BO PAAM.NS |
|
|
| Source : Asian CERC |
|
Online
